[THYMOSIN ALFA 1,A NEW BIOLOGIC RESPONSE MODIFIER FOR THE TREATMENT OF VIRAL HEPATITIS AND HEPATOCELLULAR CARCINOMA].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru2000PMID: 12138387

Plain Language Summary

This review examines thymosin alpha-1 as a biological response modifier for treating viral hepatitis and liver cancer. The peptide has been investigated in humans for chronic hepatitis B, chronic hepatitis C, and hepatocellular carcinoma, representing a class of therapy that works by modulating the immune response rather than directly attacking the virus or tumor.

Abstract

Thymosin alpha-1 is a new biologic response modifier that has been investigated in humans for treatment of chronic hepatitis B, chronic hepatitis C, and some types of cancer, particularly hepatocellular carcinoma. All these particular aspects are here reviewed.

Authors

Martins EB, Eduardo B.; Tuthill C, Cynthia